Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report) shot up 9.1% during mid-day trading on Friday . The stock traded as high as $2.80 and last traded at $2.76. 9,511 shares were traded during mid-day trading, a decline of 99% from the average session volume of 842,200 shares. The stock had previously closed at $2.53.
Ampliphi Biosciences Price Performance
About Ampliphi Biosciences
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
Featured Articles
- Five stocks we like better than Ampliphi Biosciences
- How to Capture the Benefits of Dividend Increases
- MarketBeat Week in Review – 4/22 – 4/26
- How to Read Stock Charts for Beginners
- 3 Stocks Leading the U.S. Agriculture Comeback
- What Investors Need to Know to Beat the Market
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.